Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Herrmann Ken
Over the trailing 90 days, Herrmann Ken (Other at Aktis Oncology, Inc.) traded $200K of stock (net selling $193K) in AKTS, per 9 SEC Form 4 transactions.
- Role
- Other
- Companies
- AKTS
- Window
- Trailing 90 days · 9 transactions · CIK 2049757
- Net activity
- −$193K ($3K bought · $197K sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| AKTS | Aktis Oncology, Inc. | 9 | $3K | $197K | −$193K |
Transactions (9)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-20 | AKTS | Sell | 1.4K | $0 | Exercise or conversion of derivative security |
| 2026-07-20 | AKTS | Sell | 3.5K | $86K | Open market or private sale |
| 2026-07-20 | AKTS | Sell | 1.4K | $33K | Open market or private sale |
| 2026-07-20 | AKTS | Buy | 3.5K | $280 | Exercise or conversion of derivative security |
| 2026-07-20 | AKTS | Sell | 3.5K | $0 | Exercise or conversion of derivative security |
| 2026-07-20 | AKTS | Buy | 1.4K | $3K | Exercise or conversion of derivative security |
| 2026-07-17 | AKTS | Sell | 3.1K | $0 | Exercise or conversion of derivative security |
| 2026-07-17 | AKTS | Sell | 3.1K | $77K | Open market or private sale |
| 2026-07-17 | AKTS | Buy | 3.1K | $245 | Exercise or conversion of derivative security |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Herrmann's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.